Literature DB >> 15310639

Caudal neostigmine with bupivacaine produces a dose-independent analgesic effect in children.

Rajesh Mahajan1, Vinod K Grover, Pramila Chari.   

Abstract

PURPOSE: To evaluate the analgesic efficacy and duration of varying doses of caudal neostigmine with plain bupivacaine and its side effects in children undergoing genito-urinary surgery.
METHODS: In a randomized double-blind prospective study 80 boys aged two to eight years scheduled for surgical repair of hypospadias were allocated randomly to one of four groups (n = 20 each) and received either only caudal 0.25% plain bupivacaine 0.5 mL.kg(-1) (Group I) or 0.25% plain bupivacaine 0.5 mL.kg(-1) with neostigmine (Groups II-IV) in doses of 2, 3 and 4 microg.kg(-1) respectively. Postoperative pain was assessed for 24 hr using an objective pain score. Blood pressure, heart rate, oxygen saturation, total amount of analgesic consumed and adverse effects were also recorded.
RESULTS: The duration of postoperative analgesia in Group I (5.1 +/- 2.3 hr) was significantly shorter than in the other three groups (II -16.6 +/- 4.9 hr; III - 17.2 +/- 5.5 hr; IV - 17.0 +/- 5.8 hr; P < 0.05). Total analgesic (paracetamol) consumption was significantly more in Group I (697.6 +/- 240.7 mg) than in the groups receiving caudal neostigmine (II - 248.0 +/- 178.4; III - 270.2 +/- 180.8 and IV -230.6 +/- 166.9 mg; P < 0.05). Groups II, III and IV were comparable with regards to duration of postoperative analgesia and total analgesic consumption (P > 0.05). Incidence of nausea and vomiting were comparable in all four groups. No significant alteration in vital signs or any other adverse effects were observed.
CONCLUSIONS: Caudal neostigmine (2, 3 and 4 microg.kg(-1)) with bupivacaine produces a dose-independent analgesic effect ( approximately 16-17 hr) in children as compared to those receiving caudal bupivacaine alone (approximately five hours) and a reduction in postoperative rescue analgesic consumption without increasing the incidence of adverse effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310639     DOI: 10.1007/bf03018429

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

1.  Epidural administration of neostigmine-loaded nanofibers provides extended analgesia in rats.

Authors:  Masoomeh Yosefifard; Majid Hassanpour-Ezatti
Journal:  Daru       Date:  2014-11-18       Impact factor: 3.117

Review 2.  Use of neostigmine in the management of acute postoperative pain and labour pain: a review.

Authors:  Ashraf S Habib; Tong J Gan
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

Review 4.  The evolution of spinal/epidural neostigmine in clinical application: Thoughts after two decades.

Authors:  Gabriela Rocha Lauretti
Journal:  Saudi J Anaesth       Date:  2015-01

5.  Comparison between the intravenous and caudal routes of sufentanil in children undergoing orchidopexy and further evaluation of the association of caudal adrenaline and neostigmine.

Authors:  Gabriela Rocha Lauretti; Vera Maria Silveira de Azevedo; Bruno Carvalho Portes Lopes; Anita Leocadia de Mattos
Journal:  Saudi J Anaesth       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.